Skip to content

Abnormal Circulating Igm Concentration C5139423

Published: July 22, 2026Updated: August 20, 2026

A condition with abnormal IgM antibody levels, the first antibody made during infection. Can affect anyone. Treatment involves identifying and managing the underlying cause.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Hyperviscosity syndrome

Thickened blood causing blurred vision, headache, dizziness, and chest pain due to high immunoglobulin levels.

This is a medical emergency. Seek immediate care if experiencing chest pain, vision changes, confusion, or severe headache.

!

Stroke symptoms

Sudden onset of weakness, speech difficulties, or facial drooping due to blood vessel blockage from hyperviscosity.

This is a medical emergency. Call emergency services immediately if experiencing any stroke symptoms.

Persistent fatigue

(constitutional)

Generalized tiredness and weakness that does not improve with rest, often due to immune system dysfunction.

Frequency: 70-80% of patients

Easy bruising or bleeding

(hematologic)

Increased tendency to develop bruises and prolonged bleeding from minor cuts due to platelet dysfunction.

Frequency: 40-50% of patients

Recurrent infections

(immunologic)

Frequent bacterial, viral, or fungal infections due to impaired antibody function and immune response.

Frequency: 50-60% of patients

Peripheral neuropathy

(neurologic)

Numbness, tingling, or burning sensations in extremities due to nerve involvement from abnormal proteins.

Frequency: 15-25% of patients

Skin rash or lesions

(dermatologic)

Various skin manifestations including rash, purpura, or ulcerated lesions may appear.

Frequency: 20-30% of patients

Chronic diarrhea

(gastrointestinal)

Persistent loose stools that may be watery or contain blood, often due to intestinal involvement.

Frequency: 15-20% of patients

Lymphadenopathy

(immunologic)

Enlarged lymph nodes, particularly in neck, armpits, or groin, due to immune system overactivity.

Frequency: 10-15% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Liver Function Assessment

Comprehensive hepatic panel and imaging to evaluate for liver disease, as IgM abnormalities often correlate with cholestatic conditions. Early detection allows for timely intervention.

monitoring
3

Comprehensive Immunoglobulin Profiling

Full immunoglobulin panel including IgG, IgA, and IgM to characterize the specific deficiency pattern and guide replacement strategies.

monitoring

Additional treatment options

Ursodeoxycholic Acid Therapy

For IgM abnormalities associated with cholestatic liver disease, this bile acid medication may improve bile flow and reduce hepatic inflammation.

medication

Fat-Soluble Vitamin Supplementation

Replacement of vitamins A, D, E, and K which may be malabsorbed with impaired bile acid circulation. Monitoring of vitamin levels guides supplementation dosing.

dietary

Alcohol Avoidance

Complete abstinence from alcohol to prevent additional hepatic stress and preserve remaining liver function. Support programs may assist with cessation.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Circulating Igm Concentration C5139423?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

European Society for Immunodeficiencies. ESID Registry - Diagnostic Criteria for Primary Immunodeficiencies. 2023.

guideline2023View source →
2

Cunningham-Rundles C. How I treat common variable immune deficiency. Blood. 2010;116(1):7-15.

review2010View source →
3

Bonilla FA, Barlan I, Chapel H, et al. International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. J Allergy Clin Immunol Pract. 2016;4(1):38-59.

guideline2016View source →
4

Castro AG, Neighbors K, Risma K. Approach to Elevated Immunoglobulin M. Pediatr Clin North Am. 2022;69(3):505-520.

review2022View source →
5

WHO Expert Committee on Biological Standardization. WHO Technical Report Series 1024: WHO International Standard for Immunoglobulins. 2019.

guideline2019View source →
6

Stiehm ER, Ochs HD, Winkelstein JA. Immunologic Disorders in Infants and Children. 5th ed. Elsevier; 2023.

textbook2023
7

Chapel H, Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs). Clin Exp Immunol. 2019;195(3):354-365.

review2019View source →
8

Ameratunga R, Woon ST, Gill D, et al. New Zealand Primary Immunodeficiency Group Consensus Document on the Diagnosis and Management of Primary Immunodeficiencies. N Z Med J. 2019;132(1498):68-82.

consensus2019View source →
9

Lam MT, Coppola A, Krivan G, et al. Hyper-IgM Syndrome: A Systematic Review and Meta-Analysis of Clinical Features and Treatment Outcomes. J Clin Immunol. 2022;42(6):1197-1212.

meta_analysis2022View source →
10

Jolles S, Chapel H, Lucas M, et al. Clinical Guidelines for Immunoglobulin Use. 2nd ed. UK Department of Health; 2021.

position_statement2021View source →

Medication Comparisons

Compare medications used to treat Abnormal Circulating Igm Concentration C5139423. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy